Evidence map›Paper›PMID 41335109›Full record

ArticleMicrobiology spectrum2026

Clinical impact of BioFire Blood Culture Identification 2 implementation in patients with

Colin H Duell, Tyler Ackley, Kristin E Linder, Joseph L Kuti, Alivia Castle, Rosanna Li

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Colin H DuellDepartment of Pharmacy Services, Hartford Hospital, Hartford, Connecticut, USA.ORCID 0009-0000-9727-1242
Tyler AckleyDepartment of Pharmacy Services, Hartford Hospital, Hartford, Connecticut, USA.ORCID 0000-0001-7977-5068
Kristin E LinderDepartment of Pharmacy Services, Hartford Hospital, Hartford, Connecticut, USA.
Joseph L KutiCenter for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut, USA.ORCID 0000-0002-4464-3126
Alivia CastleSchool of Pharmacy and Physician Assistant Studies, The University of Saint Joseph, West Hartford, Connecticut, USA.
Rosanna LiDepartment of Pharmacy Services, Hartford Healthcare, Hartford, Connecticut, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The BioFire Blood Culture Identification 2 (BCID2) PCR panel allows for rapid identification of blood pathogens, including Staphylococci other than IMPORTANCE: PCR-based blood culture testing with concurrent antimicrobial stewardship program review continues to facilitate the initiation of pathogen-targeted antimicrobials in a shorter amount of time compared to traditional methods. The initiation of pathogen-targeted antimicrobials compared to non-pathogen-targeted antimicrobials has been shown to improve clinical outcomes in bloodstream infections caused by specific pathogens (e.g., methicillin-susceptible

Indexed as

BacteremiaBlood CultureStaphylococcal InfectionsStaphylococcusAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansMaleMiddle AgedPolymerase Chain ReactionRetrospective StudiesStaphylococcus aureusVancomycinAnti-Bacterial AgentsVancomycinantimicrobial stewardshipbacteremiabloodstream infectionsrapid diagnostic tests

Identifiers

PMID41335109
PMCPMC12772346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.